Oncternal Therapeutics logo

Oncternal Therapeutics

ONCT | NASDAQ
Chart Builder DCF Calculator
$0.53
-$0.16 (-23.63%)
At close: Dec 02, 2024, 04:00 PM ET
-23.63%

Rating

Updated: Sep 30, 2026
21
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $1.56M
1D Range
0.53 0.70
52W Range
0.53 10.61

Valuation (TTM)

PE -0.05
PB 0.17
EV/EBITDA 0.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $28.00
Loading financial charts...

Profile

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating cancer treatments for diseases where current medical options are insufficient. Its clinical-stage portfoli...

Sector Healthcare
Industry Biotechnology
Employees 27
IPO Date Feb 3, 2004
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.